Companies / Septerna, Inc.

Septerna, Inc.

Nasdaq: SEPNCIK 1984086SOUTH SAN FRANCISCO, CA

Financials · FY2025

Revenue$45.95M
Net income$-48.88M
Total debt—
Cash$84.66M
Diluted EPS$-1.10
Shares outstanding46.7M

Ownership

46.7M shares outstanding · as of Aug 5, 2026
0.37%Insiders
Ownership
Insiders0.37%175,002
Institutions99.94%46,649,446
Public float0.00%0

Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 14

View all →
Insider% of sharesShares
Bhatt ElizabethPresident and COO
0.37%174,209
Shaikhly SamiraChief People Officer
<0.01%793
Finer JeffreyCEOChief Executive Officer · Director
——
Kim Jae B.Chief Medical Officer
——
Klein UweSVP, Biological Sciences
——
Kolchinsky PeterDirector · 10% owner
——
Labrucherie Gil MChief Financial Officer
——
Long Daniel D.SVP, Drug Discovery
——
RA Capital Healthcare Fund LPDirector · 10% owner
——
RA Capital Management, L.P.Director · 10% owner
——

Institutional holders 130

View all →
HolderValue% of shares
Trv Gp V, LLC$173.29M13.32%
RA Capital Management, L.P.$168.11M14.99%
Driehaus Capital Management LLC$134.09M10.30%
Trv Gp VI, LLC$117.42M9.02%
Samsara BioCapital, LLC$87.80M6.75%
The Goldman Sachs Group, Inc.$75.70M5.82%
BlackRock, Inc.$64.71M4.14%
Siren, L.L.C.$55.76M4.28%
Vanguard Group Inc$42.05M3.23%
Avoro Capital Advisors LLC$37.29M2.87%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Mar 2, 2026Shaikhly Samira
Executive
SellCommon Stock$1.87M-66K
-98.82%
793
<0.01% of shares
medium
Mar 2, 2026Shaikhly Samira
Executive
SellCommon Stock$112.5K-4K
-5.74%
67,156
0.14% of shares
medium
Mar 2, 2026Shaikhly Samira
Executive
ExerciseCommon Stock$83.3K+54K
+6773.52%
54,507
0.12% of shares
low
Feb 18, 2026Bhatt Elizabeth
Executive
SellCommon Stock$62.6K-2K
-1.23%
176,009
0.38% of shares
low
Feb 18, 2026Bhatt Elizabeth
Executive
SellCommon Stock$53.2K-2K
-1.02%
174,209
0.37% of shares
low
Mar 2, 2026Shaikhly Samira
Executive
ExerciseCommon Stock$32.1K+12K
+21.35%
66,145
0.14% of shares
low
Feb 18, 2026Bhatt Elizabeth
Executive
ExerciseCommon Stock$27.2K+4K
+2.30%
178,209
0.38% of shares
low
Mar 2, 2026Shaikhly Samira
Executive
ExerciseCommon Stock$14.1K+5K
+7.71%
71,246
0.15% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Biotechnology Value Fund L PPassive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
SEPNCommon StockEquity81734D104BBG014WY1V28